JFL Life Sciences Limited IPO
NSE SMEListed On: Sep 8, 2022 at ₹ 70.00
₹ 122000 /2000 Shares
Check AllotmentIPO Details
25 Aug, 2022
Open Date30 Aug, 2022
Close Date06 Sep, 2022
Allotment Date08 Sep, 2022
Listing DateIssue Price
₹61 per equity shareFace Value
₹10 Per Equity ShareListing at Group
NSE SMERegistrar
KFin Technologies LimitedList Price
70.00Listing Date
2022-09-08Market Lot
2000 Shares (₹122,000/-)Lead Manager
GYR Capital Advisors LimitedIssue Size
2,978,000 shares of ₹10(aggregating up to ₹18.17 Cr)Retail Portion
N/ASubscription
8.93 timesIPO Subscription Details
As on | QIB / NII | Retail | Total |
---|---|---|---|
Shares Offered / Reserved | 1,414,000 | 1,414,000 | 2,828,000 |
Day 1 - 25-08-22 06:00 PM | 0.24 x | 0.75 x | 0.49 x |
Day 2 - 26-08-22 06:00 PM | 0.51 x | 1.65 x | 1.08 x |
Day 3 - 29-08-22 06:00 PM | 0.66 x | 3.71 x | 2.19 x |
Day 4 - 30-08-22 06:00 PM | 6.19 x | 11.66 x | 8.93 x |
Valuations
Earnings Per Share (EPS)
₹0.76/-P/E Ratio
N/ARoNW
7.18%Net Asset Value (NAV) - Post Issue
₹138.29/-Company Financials All values are in ₹ Lakh
31-Aug-19 | 31-Mar-20 | 31-Mar-21 | 28-Feb-22 | |
---|---|---|---|---|
Assets | 1614.96 | 2432.59 | 2900.69 | 3662.86 |
Revenue | 3177.96 | 3020.41 | 3286.89 | 2563.06 |
Profit After Tax | 30.25 | 36.04 | 54.21 | 253.28 |
About The Company
JFL Life Sciences Limited is engaged in the business of manufacturing of pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets & Capsules (B-Lactam) solid oral dosage form and Tablet and capsules (general) Solid Oral Dosage Form and Oral rehydration solutions (ORS).
The company's sales strategy is to sell the products in bulk to pharmaceutical marketers and traders who in turn provide the channel for sales to customers. JFL Life Sciences Limited has a market presence in PAN India and JFL's products are supplied to 10 developed and developing countries throughout the World.
JFL Life Sciences Limited exports products to African, Middle Eastern, and CIS countries, mainly through merchant exporters. The company is registered with the MOH of Kenya, Nigeria, Yemen, Cambodia & Myanmar for manufacturing a particular product. Few of our products are also registered with Ukraine, Uzbekistan, and Kazakhstan (CIS countries) through merchants.
JFL has two manufacturing units (on lease) in Gujarat.
- Promoter(s)
Pre Issue Share Holding: 92.52%
Post Issue Share Holding: %
Company Promoter(s)
- Smiral Ashwinkumar Patel
- ejal Smiral Patel
IPO - Issue Objectives
- Repayment of secured and unsecured loans.
- Funding the working capital requirements of the company.
- General Corporate Purposes
IPO - FAQs
Ans. JFL Life Sciences Limited IPO is a SME IPO. The issue is priced at ₹61 per equity share. The minimum order quantity is 2000 Shares. The IPO opens on Aug 25, 2022, and closes on Aug 30, 2022. KFin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Ans. The JFL Life Sciences Limited IPO opens on Aug 25, 2022 and closes on Aug 30, 2022.
Ans. The size of JFL Life Sciences Limited IPO is 2,978,000 shares of ₹10(aggregating up to ₹18.17 Cr).
Ans. The IPO price band is set between ₹61 per equity share.
Ans. To apply for JFL Life Sciences Limited IPO IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find JFL Life Sciences Limited IPO in the List of IPOs
- - Press "Apply" Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of JFL Life Sciences Limited IPO is Sep 6, 2022.
Ans. The JFL Life Sciences Limited IPO will be listed on Sep 8, 2022.
Ans. Follow the steps to check the allotment status for JFL Life Sciences Limited IPO here.